Global integration poses unprecedented challenges to human health, and there is an urgent need to train and produce a new generation of leaders with international standards and comprehensive capabilities, to carry out innovative research, reform innovation systems and comprehensively enhance innovation capabilities in response to key bottlenecks. Innovation and development in the field of life medicine, clinical research and regulatory approval are two important links, shouldering the scientific assessment of the safety and importance of candidate drugs and medical devices, is a huge and complex system engineering, is the fundamental guarantee to promote the transformation of innovation results. To this end, Tsinghua University School of Medicine, in collaboration with GlaxoSmithKline, has trained postdoctoral students in "clinical research" and "regulatory science" at Tsinghua University. It is hoped that aspiring students will sign up, broaden their horizons, improve their abilities and display their talents, and make outstanding contributions to the health and well-being of "Healthy China" and the people of the world. The postdoctoral research objectives and selection requirements are as follows:
Track 1: Clinical Development Fellowship
Overall Goal: The Clinical Development Fellowship program is a post graduate research program with a strong emphasis on training and developing the successful Tsinghua medical school graduates who are selected to participate. The Fellows will assist GSK clinical scientists and Clinical support functions (Clinical Pharmacology Modelling & Simulation, Data Management and Clinical Operation) on clinical development programs of GSK assets. They will receive all necessary GSK trainings and assigned individual projects under the close supervision of GSK staff. The overall objective of the program is to provide post-graduate practical training or equivalent in the principles and applications of pharmaceutical product development and evaluation; research design and methodology, including development of research protocols in the clinical investigation of new drugs and vaccines; and principles and applications of biostatistics, advanced pharmacokinetics, laboratory drug analysis, and study design methodology.
Track 2: Regulatory Science Fellowship
Overall Goal: The goal of this fellowship is to provide on-the-job practical training and experience in key regulatory functions in order to gain expertise in the regulatory requirements of drug and vaccine development. The fellowship program is a post-graduate training program with a strong emphasis on attracting talents and developing successful Tsinghua candidates who are selected to participate. The Fellows will collaborate with members of the GSK China Regulatory Department and GSK China Development staff to provide regulatory support for clinical development and other GSK programs. Overall, this program should enhance the knowledge and real-world experience of the fellow and develop a regulatory practitioner prepared for the pharmaceutical industry or academia once the fellowship is completed.
Track 3: Artificial Intelligence/Machine Learning Fellowship
Overall Goal: In recent years, with the continuous advancement of artificial intelligence technology, its application in the field of drug development has become increasingly important. Artificial intelligence can help researchers improve efficiency and accuracy in various stages of drug development, thereby shortening the drug development cycle, reducing costs, and bringing more effective drugs and vaccines to people faster. In this project, postdoctoral researchers will work with experts from GSK China Development to explore the application of various artificial intelligence and machine learning technologies in the clinical trial process of new drugs and vaccines. They will learn how to use these technologies to optimize the clinical trial process of drugs and vaccines and improve efficiency and accuracy at each stage of the trial through practical operations.
The project is two years long and provides all the advantages of the Tsinghua University postdoctoral program. In addition, it provides researchers with an opportunity to work in a corporate environment and lay a solid foundation for their future career development. At the same time, they will have the opportunity to learn about the latest developments and trends in the pharmaceutical industry through working and studying at GSK.
Criteria for selection of Fellows
Fellows will be selected based on education, relevant experience, and career objectives, as well as rules and regulations set forth by the Tsinghua University for postdoctoral fellows. A post graduate degree in PharmD, MD or PhD and Fluency in English are required.
How to apply:
Candidates are requested to send their resumes and related materials to firstname.lastname@example.org . Please indicate the subject of the email to apply for Tsinghua University "clinical research" and "regulatory science" postdoctoral. Application deadline: 15.05.2023.